Aronora is engaged in the commercial development of proprietary therapeutics. Rational design of its innovative therapeutic agents is expected to result in products that may be able to reduce the growth of life-threatening blood clots without the detrimental bleeding side effects characterizing antithrombotic drugs. Its products are intended for difficult-to-treat, severe, rapidly progressing, or catastrophic thrombotic blood clotting diseases.
Bates Medical Systems LLC (BMS) is developing innovative and cost effective new technology for the detection and diagnosis of breast cancer, one of the leading causes of death among women. BMS’s Automated Breast Ultrasound System (ABUS) provides a pre-operative, non-ionizing radiation evaluation of the breast to accurately identify tumor size and location without compression.
Caring for someone who won’t get better is one of the most expensive and traumatic experiences we all will go through; Caregiven’s digital health platform guides families to the appropriate end-of-life support and services so they can spend less time overwhelmed by administrative tasks and more meaningful time with their loved-one.
Circumvent Pharmaceuticals is a drug discovery and development company focused on the high, unmet need of Batten patients.
Consano is the nation’s first 501(c)(3) crowdfunding platform for innovative medical research. Consano Honor Funds provide an easy way for individuals who are living with a chronic illness, or families who have lost a loved one to a disease, to share their stories and create a central hub for their fundraising efforts. The funds raised will then go to directly support the medical research project of that patient or family’s choice.
Cytolmage Dx develops imaging diagnostics for drug screening and personalized detection of disease.
Oregon-based Floragenex is a privately owned biotechnology company providing innovative solutions for genomic analysis in the life sciences. Since 2007, Floragenex has delivered impact results in hundreds of genomics studies focused on answering fundamental questions in genetics, ecology, evolutionary biology and biomedical research. With multiple offices located on the West Coast, Floragenex technologies permit investigation of genomes at unprecedented levels for academic, governmental and commercial researchers worldwide.
Fundamental Fitness Labs sets you in a new fitness direction by first finding a comprehensive baseline. They measure strength, flexibility, balance, speed and endurance. From there they track your progress to optimize your health and well being. They are on the forefront of pre disease and pre injury data collection.
Fundamental Fitness Labs uses technology to bring data to the consumer as well as medical and healthcare providers. They are currently developing a metabolic device that will accurately measure calorie burn, something not being done by current exercise devices and machines. It is their first step in using technology to more accurately measure fitness.
Gamma Therapeutics is an early stage biotechnology company developing novel medical devices for cardiovascular risk assessment, surgical therapy and hemorrhage control based upon the use of human clotting proteins.
Health Technology Innovations (HTI) is a Portland based startup company developing advanced medical image processing solutions using artificial intelligence and machine learning. Founded in 2017 by former Intel engineers, HTI is partnering with the Oregon Health and Science University’s National Cryo-EM Research Center to improve processing and analysis of large imaging datasets using cryogenic electron microscopy (cryo-EM), the Nobel Prize-winning imaging method that is revolutionizing structural biology.
Hemex Health is developing affordable, accurate tests for millions of people who are at risk for malaria and sickle cell disease and who lack access to viable diagnostics. The one minute, $1 Hemex malaria test is 10x to 20x more accurate than the current technology used in routine testing. Hemex’s portable solutions are designed to provide benefit quickly and effectively for healthcare workers and patients, whether in a modern clinic or remote corner of the world.
Madorra is developing the first non-hormonal, non-invasive medical device to treat vaginal dryness and atrophy. Madorra’s simple, easy-to-use device will empower the millions of breast cancer survivors and post-menopausal women suffering from vaginal dryness to improve their sexual health and return to wellness.
Motusi combines wearables with applications and cloud services to deliver a unique platform service solution focused initially on the Digital Health market.
Nelson Lab focuses on developing monoclonal antibodies for the treatment of tumors, and antigens and antibodies used as raw materials in the in vitro diagnostic reagents.
Neuralexo is a biotechnology company focused on the discovery and development of treatments for the protection of tissues at risk of ischemic injury (i.e. brain, heart, kidney). Indications include injury associated with cardiac surgery, transplantation, traumatic brain injury and stroke.
OmnEcoil Instruments is a medical device company that is currently developing a new patent-pending biopsy device.
ProMedix Inc is a medical device company aiming to develop technology to simplify diagnostic home healthcare as well as ER/Critical Care. The current product under development is a platform technology that aides in the diagnostic evaluation as well as monitoring of therapeutic interventions of multiple medical conditions including trauma, dehydration and sepsis.
Refeyn produces a disruptive new generation of analytical instruments that measure the mass of individual molecules directly in solution. Mass photometry offers an easy and universal way to characterize the structure, dynamics and function of biomolecules, accelerating research and drug discovery.
Rewire Neuroscience is a Portland startup focused on empowering the future of biomedical research by providing intelligent research tools that are powerful and affordable. We offer an array of laboratory equipment and analytics software, ranging from real-time freezer power monitoring to artificial intelligence for analyzing biomedical images.
RxHomeTest.com provides personalized health tests in collaboration with CLIA-certified labs and a physician’s network.
Senju Pharmaceutical develops health care products for the ears, eyes, nose, skin and throat. For nearly three decades, Senju has developed ophthalmological products, recently diversifying into other areas that ensure the healthy functioning of our senses. Senju collaborates with international research initiatives, academic institutions and researchers, and industry specialists to unlock medical secrets that lead to pharmaceutical breakthroughs.
Sirona Dx accelerates the pace of targeted-therapy development to improve outcomes for cancer patients. Sirona is a technology-agnostic CRO that offers specialized high complexity genomics services supporting pharmaceutical companies with their drug discovery and development programs.
Sonivate Medical (SMI) develops and markets innovative ultrasound technology. The company’s technology opens new markets for ultrasound by extending its use into new classes of procedures and new clinical settings. The SonicEye, SMI’s first product, is a fingertip-mounted ultrasound probe that combines ultrasound imaging with simultaneous tactile feedback, while leaving both hands free to do work. 2012 BVC, 2013 WAC launch company winners.
Nearly 2 million Americans are on long-term corticosteroid therapy to treat diseases such as rheumatoid arthritis, asthma, vasculitis, and blood cancers. To control their disease those patients face the high adverse effects risk of corticosteroids. Drug adverse effects, of which corticosteroids are responsible for 10%, cost up to $30B per year in the US.
Sparrow Pharmaceuticals is developing safer corticosteroids. Those will provide patients a new standard of care that is effective, safe, cost-effective, and convenient. A tablet form will start Phase 2 clinical trials in 2019. Other forms, such as ocular, topical, and inhaled, can also be developed utilizing the same patented technology.
StoneStable, Inc. has developed nano-technology to protect vaccines from spoilage and allows transportation and distribution at ambient temperature, eliminating the “cold-chain”. Every year 1.5 million children die from vaccine preventable diseases, many because they do not have access to vaccines. Moreover, up to 50% of vaccines, a $25 billion industry, are wasted due to problems with refrigerated transportation and storage. StoneStable, Inc. solves these problems. In addition StoneStable Inc’s technology enhances vaccine function allowing lower dosage.
SutureGard Medical is a preproduction stage medical device company. The Suturegard device is an elegant bioengineered redesign of the classic suture retention bridge and is deemed Class1, 510k exempt.
Developing Non-Invasive Neuromodulation Therapies for Parkinson’s Disease.
Established in 2012, Veana Therapeutics, Inc., is a privately held Oregon-based biotechnology company whose business strategy is to identify Alpha-TEA-based cancer immunotherapy technologies.
Alpha-TEA immunotherapy technologies are based on orally bioavailable anti-cancer agents that simultaneously kill tumor cells and stimulate the immune system. Alpha TEA platform products can be combined with other forms of immunotherapy to further improve anti-tumor activity.
Working at the interface between biology and microelectronics.
Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate.
Virogenomics BioDevelopment is focused on translating pre-clinical research from top universities and companies to commercial products.